Dermata Therapeutics
DRMA · NASDAQ
$0.8699+$0.01 (+1.16%)TodayMarket closed ·
Prev close $0.8599
Who owns DRMA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 32.0% of DRMA’s shares.
- Proehl (Gerald T)15.2%
- Van Hoose (Kyri K)5.8%
- Intracoastal Capital, L.L.C.3.7%
- Proehl Investment Ventures LLC2.0%
- Next 6 largest institutions5.3%
- All other shareholders68.0%
| Holder | Shares | % of shares |
|---|---|---|
| Proehl (Gerald T) | 612.85K | 15.25% |
| Van Hoose (Kyri K) | 232.46K | 5.78% |
| Intracoastal Capital, L.L.C. | 147.06K | 3.66% |
| Proehl Investment Ventures LLC | 79.95K | 1.99% |
| Bigger Capital Funds, LP | 75.20K | 1.87% |
| District 2 Capital LP | 61.00K | 1.52% |
| Geode Capital Management, L.L.C. | 20.20K | 0.50% |
| Welch & Forbes LLC | 20.00K | 0.50% |
| Fisher (Mary) | 19.69K | 0.49% |
| State Street Investment Management (US) | 18.75K | 0.47% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 19.10K | 0.48% |
| Fidelity Series Total Market Index Fund | 1.11K | 0.03% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $13 (1 trade) of DRMA on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Van Hoose Kyri K. | Award | 102.04K | — |
| Van Hoose Kyri K. | Award | 102.04K | — |
| Van Hoose Kyri K. | Award | 102.04K | — |
| PROEHL GERALD T | Award | 1.36M | — |
| PROEHL GERALD T | Award | 170.07K | — |
| PROEHL GERALD T | Award | 170.07K | — |
| PROEHL GERALD T | Award | 1.36M | — |
| PROEHL GERALD T | Award | 1.36M | — |
| PROEHL GERALD T | Award | 170.07K | — |
| Scott Kathleen D. | Sale | 11 | $13 |
Short interest
Settled Sep 30, 2026
- Shares short
- 84.48K
- Days to cover
- 3.61
- % of shares outstanding
- 2.10%
- Average daily volume
- 23.43K
- Change since last report
- −29.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.